USPTO serial 79250945
SMARTPHLEX
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- May 26, 2020
- Examiner
- CHOE, JULIE H
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with SMARTPHLEX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,795*
Plus Government fees of $2,125
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Mark J. Liss
Mark J. Liss LEYDIG, VOIT & MAYER, LTD.180 North Stetson Avenue, Suite 4900Chicago, IL 60601UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Software for supporting product development processes and regulatory compliance; software for automation of routine processes and report generation; artificial intelligence software for supporting decision making processes; computer programs for data processing; downloadable computer software applications for supporting product development processes and regulatory compliance; unified communications software for supporting decision making processes; assistive software for supporting product development processes and regulatory compliance; all the foregoing in the fields of medical devices, consumer healthcare, animal healthcare, pharmaceuticals and biopharmaceuticals | ACTIVE | — |
| 035 | Advertising services, business management for others, company administration in the nature of business administration services; business efficiency expert services; systemization of information into computer databases; compilation of information into computer databases; business assistance and consultancy services in the field of retailing services and wholesaling services related to medicines; provision of outsourcing services in the field of business management for companies engaged in the field of medicine development, authorization, production, sale, safety and monitoring; assistance and consultancy in the field of business management of companies engaged in medicine and medical device authorization and lifecycle maintenance, namely, automation of content compilation and document dossier development, automation for creation of documents for achieving medical marketing authorization and marketing approval; regulatory submission management, namely, assisting others in filing of documents with regulatory authorities for authorizing and lifecycle maintenance of medicines and medical devices using documents, reports and files required by regulatory authorities via automation of content compilation and document dossier development, automation for creation of documents for achieving medical marketing authorization and marketing approval | ACTIVE | — |
| 040 | Assistance and consultancy in the context of medicine production, namely, manufacturing process consulting | ACTIVE | — |
| 042 | Scientific and technological services and research and design relating thereto, namely, scientific research and laboratory research in the field of pharmaceuticals; industrial analysis and research services, namely, laboratory research services relating to pharmaceuticals and pharmaceutical research services; research and development of new products for others in the field of pharmaceuticals; provision of scientific surveys in the field of pharmaceuticals in the nature of scientific research; development of a web application for inputting and using informative texts for medicines and medical products, in particular user guides, packaging inserts, specialist information, and for providing various documents; database services, namely, electronic storage of data in computer databases; conversion of data or documents from physical to electronic media; scientific research; scientific research and analysis in the field of pharmaceuticals; pharmaceutical product evaluation; consultancy pertaining to pharmacology; consultancy relating to research and development in the field of therapeutics; consultancy relating to laboratory testing; pharmaceutical products development; development of pharmaceutical preparations and medicines; testing of pharmaceuticals; provision of information and data relating to medical and veterinary research and development; inspection of pharmaceuticals; scientific investigations for medical purposes; conducting early evaluations in the field of new pharmaceuticals; pharmaceutical drug development services; medical laboratory services; information technology consultancy services provided to the pharmaceutical and healthcare industries; scientific assessment of the efficiency of medicines; services for assessing the efficiency of pharmaceuticals, namely, pharmaceutical product evaluation; new product design services, namely, analysis and evaluation of product design; product development consultation, namely, analysis and evaluation of new product development; quality control testing for others, namely, product testing; materials testing and evaluation; product safety testing; quality control services, namely, testing, analysis and evaluation of the services of others to determine conformity with certification standards; quality testing of products for others to determine conformity with certification standards; development, updating and maintenance of software and database systems; development of software for data and multimedia content conversion from and to different protocols; Providing temporary use of on-line, non-downloadable software for publishing and printing written materials for improving gains in efficiency with client operations; providing temporary use of on-line non-downloadable software for the management of information; providing temporary use of on-line non-downloadable software for the transmission of information; providing temporary use of on-line non-downloadable software for the transmission of data; providing temporary use of on-line non-downloadable software for the management of data; software as a service (SAAS) services featuring software for the management and transmission of information and data; rental of software for data processing; all the foregoing in the fields of medical devices, consumer healthcare, animal healthcare, pharmaceuticals and biopharmaceuticals | ACTIVE | — |
| 044 | Medical and veterinary medical services; pharmacy advice in the nature of pharmaceutical advice; providing information relating to medicine; providing information relating to the preparation and dispensing of medications; advisory services relating to pharmaceuticals, namely, pharmaceutical advice | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by PharmaLex GmbH
- Other trademarks owned by PharmaLex GmbH
- Other trademarks owned by PharmaLex GmbH
- Other trademarks in Class 009
- Other trademarks in Class 035
- Other trademarks in Class 040
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named SMARTPHLEX
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 26, 2025 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Nov 15, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 18, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 17, 2020 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 24, 2020 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Sep 24, 2020 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Aug 26, 2020 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| May 26, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 21, 2020 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Mar 10, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 10, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 6, 2020 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Feb 19, 2020 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Feb 19, 2020 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Feb 19, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 3, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 31, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 31, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jan 31, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jan 31, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 28, 2020 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jan 28, 2020 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 28, 2020 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 13, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 13, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 13, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 4, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 4, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 4, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 8, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 8, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 5, 2019 | ALIE | ASSIGNED TO LIE | — |
| Jul 30, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 16, 2019 | RFNT | REFUSAL PROCESSED BY IB | — |
| Feb 22, 2019 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 21, 2019 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Feb 13, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 12, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 12, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 6, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 6, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 31, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |